Two Sigma Investments
APTO

Two Sigma Investments’s Aptose Biosciences, Inc. APTO Stock Holding History

Two Sigma Investments’s Portfolio APTO Stock Details APTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-96
Closed -$27.6K – 3407
2023
Q1 		$27.6K Sell
96
-36
-27% -$10.5K ﹤0.01% 2825
2022
Q4 		$34.4K Sell
132
-60
-31% -$16.1K ﹤0.01% 2632
2022
Q3 		$51K Buy
192
+26
+16% +$8.96K ﹤0.01% 2315
2022
Q2 		$55K Sell
166
-809
-83% -$387K ﹤0.01% 2336
2022
Q1 		$597K Sell
975
-556
-36% -$307K ﹤0.01% 1937
2021
Q4 		$930K Buy
1,531
+1,045
+215% +$982K ﹤0.01% 2619
2021
Q3 		$477K Buy
+486
New +$608K ﹤0.01% 3309
2020
Q3 		– Sell
-124
Closed -$353K – 3690
2020
Q2 		$353K Buy
+124
New +$400K ﹤0.01% 2265
2020
Q1 		– Sell
-186
Closed -$473K – 4003
2019
Q4 		$473K Buy
+186
New +$242K ﹤0.01% 2843

Other funds holding APTO

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
AC
Annandale Capital Dallas, Texas $709M AUM 11.03% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Two Sigma Investments's APTO Position: Q2 2023 in Review

Two Sigma Investments sold out of Aptose Biosciences, Inc. (APTO) in Q2 2023, closing a stake of 96 shares — an estimated $27.6K sold.

Two Sigma Investments first reported a position in APTO in Q4 2019 and held it in 9 quarters. The position peaked at $930K in Q4 2021. 24 funds tracked by Wall St. Rank hold APTO as of Q2 2023.

  • Two Sigma Investments reported no remaining Aptose Biosciences, Inc. position as of Q2 2023 after selling out during the quarter.
  • Two Sigma Investments sold 96 Aptose Biosciences, Inc. shares in Q2 2023, an estimated $27.6K.
  • Two Sigma Investments first reported a position in Aptose Biosciences, Inc. in Q4 2019 and held it in 9 quarters.
  • Two Sigma Investments's Aptose Biosciences, Inc. position peaked at $930K in Q4 2021.
  • 24 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q2 2023.

Based on Two Sigma Investments's 13F filing for Q2 2023, filed 14 Aug 2023.